Several imaging agents have been developed to monitor and examine changes in PR levels, and researchers at the University of Wisconsin School of Medicine and Public Health now studied if the 18F-fluorofuranylnorprogesterone (18F-FFNP) imaging agent could be used for that purpose.
Office of Strategic Communication